Technology Strategy
& Selection
We act as your neutral partner. We will tell you if you need a $500k enterprise system or a $50k custom build.
BUILD VS. BUY?
The market is flooded with RBQM tools. Some are over-engineered; others are vaporware. We cut through the sales pitch to find the architecture that fits your portfolio size and budget.
Vendor Selection
- RFP ManagementWe write the technical requirements and manage the vendor demonstration process.
- Scoring MatricesObjective evaluation of features, compliance, and cost of ownership.
Architecture Design
- Data Flow MappingDesigning the "Central Intelligence" architecture before you buy a single license.
- Integration StrategyDefining how EDC, CTMS, and Safety DB will talk to each other.
Roadmap Planning
- Phased RolloutStart with a pilot study, then scale. We define the milestones for success.
- Budget ForecastingRealistic estimates of implementation costs, licensing, and maintenance.
FREQUENTLY ASKED QUESTIONS
When should I consider custom development vs. buying an enterprise RBQM platform?
If you have unique data sources (e.g., wearables, patient registries) or need specific analytics not available in commercial platforms, custom development may be more cost-effective. However, if your needs align with standard RBQM workflows (centralized monitoring, KRI tracking, triggered visits), enterprise platforms like Medidata or Veeva offer faster time-to-value. We conduct a build-vs-buy analysis to help you make this decision based on your specific requirements, budget, and timeline.
How do you help us select the right RBQM platform?
We start by understanding your existing technology stack (EDC, CTMS, ePRO), your study portfolio (phase, therapeutic area, complexity), and your organizational priorities (ease of use, advanced analytics, cost). We then conduct a structured platform evaluation across 10 dimensions—data integration, KRI library, user experience, reporting, pricing, and more. Our recommendations are platform-agnostic; we have no vendor partnerships or financial incentives. We tell you which platform best fits your needs, not which one pays us the highest commission.
What is included in a technology strategy engagement?
A typical engagement includes: (1) Current state assessment—reviewing your existing RBQM tools, processes, and pain points; (2) Requirements gathering—defining your must-have vs. nice-to-have capabilities; (3) Platform evaluation—scoring 3-5 platforms against your requirements; (4) Build-vs-buy analysis—comparing custom development costs to platform licensing; (5) Integration roadmap—defining how new tools will connect to your existing systems; (6) Phased rollout plan—outlining pilot studies, full deployment, and success metrics. Typical timeline: 3-4 weeks.
Can you help us if we've already purchased a platform but aren't using it effectively?
Yes. This is one of the most common scenarios we encounter. Many sponsors invest in enterprise RBQM platforms but struggle with low adoption rates, unclear workflows, or inadequate training. We conduct a platform optimization assessment to identify gaps in configuration, data integration, KRI design, or team training. We then provide targeted interventions—reconfiguring KRIs, building custom dashboards, conducting methodological training, or redesigning centralized review workflows—to maximize your platform ROI.
Do you have partnerships with RBQM vendors?
No. We maintain strict independence from all RBQM vendors. We do not receive commissions, referral fees, or any financial incentives from Medidata, Veeva, Oracle, CluePoints, or any other platform provider. This allows us to provide unbiased recommendations based solely on your needs. Our only incentive is to help you make the right decision for your organization.